Drug company breaks 30 year agreement on patient advertisingBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7311.470/a (Published 01 September 2001) Cite this as: BMJ 2001;323:470
- Carl Kovac
Criticism has erupted in the United States against drug companies that, in violation of a 30 year old international marketing agreement, have begun aiming their advertising of potentially addictive drugs (used to treat children's behavioural and emotional problems) directly at parents, rather than just doctors.
Among those companies is a UK firm, Celltech Pharma, whose US subsidiary, Celltech Pharmaceuticals (based in Rochester, New York), …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial